/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Characterizing patients ineligible for mitral valve intervention: Phenotypic clustering sub-analysis from the CHOICE-MI Registry
Event: ESC Congress 2023
Topic: Mitral Valve Intervention
Session: Transcatheter mitral valve interventions: how to select the proper patients
Is mitral annular calcification bad?
Event: EACVI 2023
Topic: Imaging of Valvular Heart Disease
Session: Mitral regurgitation and its secrets
Outcomes of patients with severe mitral regurgitation treated with transcatheter mitral valve implantation or medical therapy
Event: EuroEcho 2021
Topic: Imaging of Valvular Heart Disease
Session: e-posters session - Cross-Modality and Multi-Modality Imaging Topics
Repair or replace? TEER versus TMVI for secondary MR
Event: ESC Congress 2021 - The Digital Experience
Topic: Mitral Valve Intervention
Session: Registries on Valve
Risk prediction in patients with classical Low-flow, low-gradient aortic stenosis undergoing TAVI
Event: ESC Congress 2021 - The Digital Experience
Topic: Aortic Valve Intervention
Session: Highlights from the Young in Intervention
The adverse impact of HFpEF in patients with aortic stenosis: Evaluation of the H2FPEF score for risk assessment among patients with preserved ejection fraction undergoing TAVI
Event: ESC Congress 2020
Topic: Aortic Valve Intervention
Session: Optimizing Risk Stratification and Technical Aspects of TAVI Procedures
Prognostic value of high-sensitivity troponin I measured by two assays in patients presenting with suspected myocardial infarction
Event: ESC Congress 2019
Topic: Epidemiology, Prognosis, Outcome
Session: Coronary artery disease - Epidemiology, prognosis, outcome
High H2FPEF score is an independent predictor of adverse outcome in patients with severe aortic stenosis and preserved ejection fraction undergoing TAVR
Event: ESC Congress 2019
Topic: Aortic Valve Intervention
Session: TAVR outcomes: the future is here
ESC 365 is supported by
